Optimistic about WHO approval for COVAXIN exports: Niti Aayog's Dr VK Paul

As Bharat Biotech waits in anticipation of World Health Organization's (WHO) approval, Niti Aayog Member, Dr VK Paul, has portrayed optimism. Me in India, COVAXIN's approval by WHO will allow Bharat Biotech to export vaccine and furr permit international travel of iculated passengers. Previously on July 9, Bharat Biotech h submitted data required for WHO's approval.

Dr Vk Paul on WHO's approval of COVAXIN

COVAXIN is a Whole Virion Inactivated COVID Vaccine developed by Bharat Biotech in collaboration with Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV). While phase 3 trials entailed 25,800 participants between 18-98 years of including 10% over of 60, analysis was conducted 14 days after ministering second dose of vaccine.

COVAXIN h shown around 77.8% and an overall 93.4% efficiency against severe COVID diseases. Dr VK Paul said, "We kw of positive developments-data sharing, data evaluation going on through multiple reviews."

Dr Paul surmised that possibility of COVAXIN getting approved is certain and close to a decision point. He said, "We believe that positive decision could be coming in before month-end."

WHO congratulates India; Mansukh Mandaviya lauds PM Modi

WHO on Monday congratulated India for dispensing a total of 75 crore COVID vaccines. WHO t only congratulated country but also its ministration for expediting vaccination drive. Taking to his official Twitter handle, Minister of Health and Family Welfare (MoHFW) Mansukh Mandaviya first broke news.

Outlining that India has ministered 75 crore doses, Mansukh Mandaviya credited Prime Minister Narendra Modi's 'Sabka sath, sabka prayas' principle. He exuded confidence that India will continue achieving milestones in its vaccination drive one after or.

Im Credits - ANI